Skip to main content
OpenTrials
Completed

NCT Number: NCT05600348

Dose-dependent Identification of Unique Biomarkers

The purpose of the research is to assess the dose-dependent impacts of the consumption of fresh pork on blood-borne metabolites (markers) following the controlled feeding of pork

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

School of Exercise and Nutritional Sciences

San Diego, California, 92182, United States

About this study

Eligible participants will follow 3 randomly ordered 4-week feeding periods varying only with the consumption of 0, 3 or 6 oz of pork or a 50:50 blend of chicken and beef (6, 3 and 0 oz for respective trials to ensure similar total poultry/meat intake among trials).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • generally healthy (i.e., an absence of diagnosed chronic illnesses and inborn metabolic disorders)
  • Age 18-65
  • all races
  • both sexes
  • willingness to comply with the research diet requirements

Exclusion criteria

  • special dietary needs (e.g., vegetarianism, gluten-free, etc.)
  • use of medication known to influence metabolism
  • smoking
  • substance use

Treatment and study plan

Pork Consumption

Dietary Supplement

Feeding of pork is controlled at 0, 3 or 6 oz per day for 4 weeks each in random order.

Primary outcomes

  1. Metabolic biomarker discovery

    Time frame: 4 weeks

    Biomolecules detected through metabolomic profiling that will result in discovery of a metabolic signature for pork intake

Secondary outcomes

  1. Fasted Glucose

    Time frame: 4 weeks

    Fasted Glucose

  2. Insulin

    Time frame: 4 weeks

    Insulin

  3. HDL Cholesterol

    Time frame: 4 weeks

    HDL Cholesterol

  4. Total Cholesterol

    Time frame: 4 weeks

    Total Cholesterol

  5. LDL-Cholesterol

    Time frame: 4 weeks

    LDL-Cholesterol

  6. Triglycerides

    Time frame: 4 weeks

    Triglycerides

  7. Interleukin-6

    Time frame: 4 weeks

    Interleukin-6

  8. C-Reactive Protein

    Time frame: 4 weeks

    C-Reactive Protein

  9. Blood Pressure

    Time frame: 4 weeks

    Systolic and Diastolic

  10. Body Composition

    Time frame: 4 weeks

    Weight measured via scalre, body fat% muscle mass as measured via DEXA

Sponsors and collaborators

Lead sponsor

San Diego State University

Other

Registry information

Official study title

Personalized Pork: Dose-dependent Identification of Unique Biomarkers

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 31, 2022
Registry last updated
Jan 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.